Colgate-Palmolive (NYSE:CL) Price Target Cut to $80.00 by Analysts at Barclays

Colgate-Palmolive (NYSE:CL) had its price target trimmed by Barclays from $82.00 to $80.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage currently has an equal weight rating on the stock.

Several other research firms also recently commented on CL. UBS Group decreased their price objective on shares of Colgate-Palmolive from $92.00 to $90.00 and set a “buy” rating on the stock in a report on Monday. Deutsche Bank Aktiengesellschaft set a $86.00 price target on shares of Colgate-Palmolive in a research note on Friday, October 10th. Raymond James Financial cut their price objective on shares of Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating for the company in a research report on Monday, October 20th. Evercore ISI decreased their price objective on Colgate-Palmolive from $100.00 to $94.00 and set an “outperform” rating on the stock in a report on Monday. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, October 8th. Nine equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $89.87.

Colgate-Palmolive Price Performance

Shares of NYSE CL opened at $76.53 on Tuesday. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79. The business’s 50 day moving average price is $80.11 and its two-hundred day moving average price is $86.00. The company has a market cap of $61.86 billion, a PE ratio of 21.50, a price-to-earnings-growth ratio of 4.44 and a beta of 0.34. Colgate-Palmolive has a twelve month low of $74.54 and a twelve month high of $100.18.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, October 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.89 by $0.02. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The company had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.17 billion. During the same period in the previous year, the company posted $0.91 EPS. The firm’s revenue for the quarter was up 1.9% compared to the same quarter last year. On average, analysts predict that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date of this dividend is Friday, October 17th. Colgate-Palmolive’s dividend payout ratio is presently 58.26%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in CL. Personal CFO Solutions LLC purchased a new position in shares of Colgate-Palmolive during the 1st quarter valued at $285,000. Vision Capital Management Inc. bought a new stake in Colgate-Palmolive in the 1st quarter valued at about $322,000. Financial Gravity Asset Management Inc. bought a new stake in Colgate-Palmolive in the 1st quarter valued at about $2,166,000. Cidel Asset Management Inc. lifted its holdings in Colgate-Palmolive by 13.6% during the second quarter. Cidel Asset Management Inc. now owns 329,060 shares of the company’s stock valued at $29,912,000 after purchasing an additional 39,413 shares during the last quarter. Finally, Penserra Capital Management LLC boosted its position in Colgate-Palmolive by 398.6% during the first quarter. Penserra Capital Management LLC now owns 10,651 shares of the company’s stock worth $997,000 after purchasing an additional 8,515 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.